Beta-blocker migraine prophylaxis affects the excitability of the visual cortex as revealed by transcranial magnetic stimulation

Journal of Headache and Pain

Volumn 13, Issue 1, 2012, Pages 83-89

  Gerwig, Marcus ^a   Niehaus, L ^b   Stude, P ^c   Katsarava, Z ^a   Diener, H C ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Cortical excitability; Migraine prophylaxis; Phosphene threshold; Transcranial magnetic stimulation

Indexed keywords

METOPROLOL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; MALE; MIGRAINE; MOTOR ACTIVITY; NERVE EXCITABILITY; PRIORITY JOURNAL; TRANSCRANIAL MAGNETIC STIMULATION; VISUAL CORTEX; VISUAL THRESHOLD;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; EVOKED POTENTIALS, MOTOR; FEMALE; HUMANS; MALE; METOPROLOL; MIDDLE AGED; MIGRAINE DISORDERS; PHOSPHENES; TRANSCRANIAL MAGNETIC STIMULATION; VISUAL CORTEX; YOUNG ADULT;

EID: 84859606776     PISSN: 11292369     EISSN: 11292377     Source Type: Journal    
DOI: 10.1007/s10194-011-0401-x     Document Type: Article

References (47)

1. Diener H, Limmroth V (2004) Prevention of migraine: betablockers and amine agonists efficacy. In: Olesen J, Silberstein S, Tfelt-Hansen P (eds) Preventive pharmacotherapy of headache disorders. Oxford University Press, Oxford, pp 59-66
2. Silberstein SD (2009) Preventive migraine treatment. Neurol Clin 27:429-443
3. Kropp P, Gerber WD (1995) Contingent negative variation during migraine attack and interval: evidence for normalization of slow cortical potentials during the attack. Cephalalgia 15:123-128
4. Schoenen J (2009) Abnormal cortical information processing between migraine attacks. In: Sandler M, Ferrari M, Harnett S (eds) Migraine: pharmacology and genetics. Altman, London, pp 233-253
5. Vincent M, Pedra E, Mourao-Miranda J, Bramati IE, Henrique AR, Moll J (2003) Enhanced interictal responsiveness of the migraineous visual cortex to incongruent bar stimulation: a functional MRI visual activation study. Cephalalgia 23:860-868 (Pubitemid 37352622)
6. Schoenen J, Ambrosini A, Sandor PS, Maertens de Noordhout A (2003) Evoked potentials and transcranial magnetic stimulation in migraine: published data and viewpoint on their pathophysiologic significance. Clin Neurophysiol 114:955-972 (Pubitemid 36694753)
7. Schoenen J, Maertens A, Timsit-Berthier M, Timsit M (1985) Contingent negative variation (CNV) as a diagnostic and physiopathologic tool in headache patients. In: Rose FC (ed) Migraine. Clinical and research advances. Karger, Basel, pp 17-25
8. Schoenen J, Timsit-Berthier M, Timsit M (1985) Correlations between contingent negative variation and plasma levels of catecholamines in headache patients. Cephalalgia 5(Suppl 1):480
9. Schoenen J, Wang W, Albert A, Delwaide PJ (1995) Potentiation instead of habituation characterizes visual evoked potentials in migraine patients between attacks. Eur J Neurol 2:115-122
10. Kropp P, Gerber WD (1993) Contingent negative variationfindings and perspectives in migraine. Cephalalgia 13:33-36 (Pubitemid 23056931)
11. Afra J, Mascia A, Gérard P, Maertens de Noordhout A, Schoenen J (1998) Interictal cortical excitability in migraine. A study using transcranial magnetic stimulation of motor and visual cortices. Ann Neurol 44:209-215 (Pubitemid 28374109)
12. Wang W, Wang YH, Fu XM, Sun ZM, Schoenen J (1999) Auditory evoked potentials and multiple personality measures in migraine and post-traumatic headaches. Pain 79:235-242 (Pubitemid 29076758)
13. Schoenen J, Maertens de Noordhout A, Timsit-Berthier M, Timsit M (1986) Contingent negative variation and efficacy of betablocking agents in migraine. Cephalalgia 6:229-233 (Pubitemid 17227804)
14. Diener HC, Scholz E, Dichgans J, Gerber WD, Jack A, Bille A, Niederberger U (1989) Central effects of drugs used in migraine prophylaxis evaluated by visual evoked potentials. Ann Neurol 25:125-130 (Pubitemid 19051244)
15. Sándor PS, Afra J, Ambrosini A, Schoenen J (2000) Prophylactic treatment of migraine with beta-blockers and riboflavin: differential effects on the intensity dependence of auditory evoked cortical potentials. Headache 40:30-35 (Pubitemid 30091515)
16. Schoenen J (1997) Clinical neurophysiology of headache. Neurol Clin 15:85-105
17. Aurora SK, Ahmad BK, Welch KMA, Bhardhwaj P, RamadanNM (1998) Transcranial magnetic stimulation confirms hyperexcitability of occipital cortex in migraine. Neurology 50:1111-1114 (Pubitemid 28212846)
18. Aurora SK, Welch KM, Al-Sayed F (2003) The threshold for phosphenes is lower in migraine. Cephalalgia 23:258-263 (Pubitemid 36577942)
19. Mulleners WM, Chronicle EP, Palmer JE, Koehler PJ, Vredeveld JW (2001) Visual cortex excitability in migraine with and without aura. Headache 41:565-572 (Pubitemid 32619260)
20. Battelli L, Black KR, Wray SH (2002) Transcranial magnetic stimulation of visual area V5 inmigraine. Neurology 58:1066-1069 (Pubitemid 34298547)
21. Young WB, Oshinsky ML, Shechter AL, Gebeline-Myers C, Bradley KC, Wassermann EM (2004) Consecutive transcranial magnetic stimulation: phosphene thresholds in migraineurs and controls. Headache 44:131-135 (Pubitemid 38233754)
22. Gerwig M, Niehaus L, Kastrup O, Stude P, Diener HC (2005) Visual cortex excitability in migraine evaluated by single and paired magnetic stimuli. Headache 45:1394-1399 (Pubitemid 350004952)
23. Bohotin V, Fumal A, Vandenheede M, Bohotin C, Schoenen J (2003) Excitability of visual V1-V2 and motor cortices to single transcranial magnetic stimuli in migraine: a reappraisal using a figure-of-eight coil. Cephalalgia 23:264-270 (Pubitemid 36577943)
24. Artemenko AR, Kurenkov AL, Filatova EG, Nikitin SS, Kaube H, Katsarava Z (2008) Effects of topiramate on migraine frequency and cortical excitability in patients with frequent migraine. Cephalalgia 28:203-208 (Pubitemid 351172028)
25. Young W, Shaw J, Bloom M, Gebeline-Myers C (2008) Correlation of increase in phosphene threshold with reduction of migraine frequency: observation of levetiracetam-treated subjects. Headache 48:1490-1498
26. International Headache Society (2004) The international classification of headache disorders, 2nd edn. Cephalalgia 24(Suppl 1): 9-160
27. Rossini PM, Barker AT, Berardelli A (1994) Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalogr Clin Neurophysiol 91:79-92 (Pubitemid 24246462)
28. Kammer T, Beck S, Erb M, Grodd W (2001) The influence of current direction on phosphene thresholds evoked by transcranial magnetic stimulation. Clin Neurophysiol 112:2015-2021 (Pubitemid 32995968)
29. Gerwig M, Kastrup O, Meyer BU, Niehaus L (2003) Evaluation of cortical excitability by motor and phosphene thresholds in transcranial magnetic stimulation. J Neurol Sci 215:75-78 (Pubitemid 37272200)
30. Boroojerdi B, Bushara KO, Corwell B, Immisch I, Battaglia F, Muellbacher W, Cohen LG (2000) Enhanced excitability of the human visual cortex induced by short-term light deprivation. Cereb Cortex 10:529-534 (Pubitemid 30318459)
31. Holroyd KA, Penzien DB, Cordingley GE (1991) Propranolol in the management of recurrent migraine: a meta-analytic review. Headache 31:333-340
32. Linde K, Rossnagel K (2004) Propranolol for migraine prophylaxis. Cochrane Database Syst Rev (2):CD003225
33. Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, Sándor PS (2009) European Federation of Neurological Societies. EFNS guideline on the drug treatment of migraine-revised report of an EFNS task force. Eur J Neurol 16:968-981
34. Amassian VE, Cracco RQ, Maccabee PJ, Cracco JB, Rudell A, Eberle L (1998) Transcranial magnetic stimulation in study of the visual pathway. J Clin Neurophysiol 15:288-304 (Pubitemid 28402028)
35. Stewart LM, Walsh V, Rothwell JC (2001) Motor and phosphene thresholds: a transcranial magnetic stimulation correlation study. Neuropsychologia 39:415-419 (Pubitemid 32065807)
36. Boroojerdi B, Meister IG, Foltys H, Sparing R, Cohen LG, Töpper R (2002) Visual and motor cortex excitability: a transcranial magnetic stimulation study. Clin Neurophysiol 113:1501-1504
37. Maertens de Noordhout A, Timsit-Berthier M, Timsit M, Schoenen J (1987) Effects of beta blockade on contingent negative variation in migraine. Ann Neurol 21:111-112 (Pubitemid 17004156)
38. Ayata C, Jin H, Kudo C, Dalkara T, Moskowitz MA (2006) Suppression of cortical spreading depression in migraine prophylaxis. Ann Neurol 59:652-661
39. Bettucci D, Cantello R, Gianelli M, Naldi P, Mutani R (1992) Menstrual migraine without aura: cortical excitability to magnetic stimulation. Headache 32:345-347
40. Maertens de Noordhout A, Pepin JL, Schoenen J, Delwaide PJ (1992) Percutaneous magnetic stimulation of the motor cortex in migraine. Electroencephalogr Clin Neurophysiol 85:110-115
41. van der Kamp W, Maassen VanDenBrink A, Ferrari MD, van Dijk JG (1996) Interictal cortical hyperexcitability in migraine patients demonstrated with transcranial magnetic stimulation. J Neurol Sci 139:106-110
42. Brighina F, Piazza A, Daniele O, Fierro B (2002) Modulation of visual cortical excitability in migraine with aura: effects of 1 Hz repetitive transcranial magnetic stimulation. Exp Brain Res 145:177-181 (Pubitemid 34743969)
43. Brighina F, Cosentino G, Vigneri S, Talamanca S, Palermo A, Giglia G, Fierro B (2011) Abnormal facilitatory mechanisms in motor cortex of migraine with aura. Eur J Pain 15 (9):928-935 [Epub ahead of print]
44. Conte A, Barbanti P, Frasca V, Iacovelli E, Gabriele M, Giacomelli E, Aurilia C, Pichiorri F, Gilio F, Inghilleri M (2010) Differences in short-term primary motor cortex synaptic potentiation as assessed by repetitive transcranial magnetic stimulation in migraine patients with and without aura. Pain 148:43-48
45. Palermo A, Fierro B, Giglia G, Cosentino G, Puma AR, Brighina F (2009) Modulation of visual cortex excitability in migraine with aura: effects of valproate therapy. Neurosci Lett 467:26-29
46. Weiller C, May A, Limmroth V, Jüptner M, Kaube H, Schayck RV et al (1995) Brain stem activation in spontaneous human migraine attacks. Nat Med 1:658-660
47. Goadsby PJ (2002) Neurovascular headache and a midbrain vascular malformation: evidence for a role of the brainstem in chronic migraine. Cephalalgia 22:107-111